is tirzepatide available in pill form F.D.A. Approves New Obesity Drug That Will Compete With Wegovy Tirzepatide Oral | Starts at

This is particularly true during the first two years of treatment

[] This synthetic peptide, composed of 39 amino acids, is designed for once-weekly subcutaneous administration

This is clinical-grade, physician-guided therapy

After 46 weeks of treatment: 0.6 mg dose: 6.2% mean body weight reduction 2.4 mg dose: 12.5% mean body weight reduction 3.6 mg dose: 13.2% mean body weight reduction 4.8 mg dose: 14.9% mean body weight reduction (all randomized) 4.8 mg dose: 18.7% mean body weight reduction (completers only) Placebo: 2.8% mean body weight reduction Among completers at the 4.8 mg dose, 68.8% achieved at least 10% weight loss, 67% achieved at least 15%, and 40% achieved at least 20% weight loss

Pairing them adds a third receptor pathway (amylin) on top of tirzepatide's GLP-1 and GIP coverage

Results may appear sooner for some, while they may take longer for others